title: Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.
abstract: To evaluate the in vitro efficacy of common antifungal drugs, as well as the interactions of caspofungin with voriconazole, amphotericin B, or itraconazole against the pathogenic black yeast Exophiala dermatitidis from China, the minimal inhibitory concentrations (MICs) of terbinafine, voriconazole, itraconazole, amphotericin B, fluconazole, and caspofungin against 16 strains of E. dermatitidis were determined by using CLSI broth microdilution method (M38-A2). The minimal fungicidal concentrations (MFCs) were also determined. Additionally, the interactions of caspofungin with voriconazole, amphotericin B, itraconazole or fluconazole, that of terbinafine with itraconazole, or that of fluconazole with amphotericin B were assessed by using the checkerboard technique. The fractional inhibitory concentration index (FICI) was used to categorize drug interactions as following, synergy, FICI ≤ 0.5; indifference, FICI > 0.5 and ≤4.0; or antagonism, FICI > 4.0. The MIC ranges of terbinafine, voriconazole, itraconazole, amphotericin B, fluconazole, and caspofungin against E. dermatitidis were 0.06-0.125 mg/l, 0.25-1.0 mg/l, 1.0-2.0 mg/l, 1.0-2.0 mg/l, 16-64 mg/l, and 32-64 mg/l, respectively. The in vitro interactions of caspofungin with voriconazole, amphotericin B, and itraconazole showed synergic effect against 10/16(62.5%), 15/16(93.75%), and 16/16(100%) isolates, while that of caspofungin with fluconazole showed indifference. Besides, the interaction of terbinafine with itraconazole as well as that of fluconazole with amphotericin B showed indifference. Terbinafine, voriconazole, itraconazole, and amphotericin B have good activity against E. dermatitidis. The combinations of caspofungin with voriconazole, amphotericin B or itraconazole present synergic activity against E. dermatitidis. These results provide the basis for novel options in treating various E. dermatitidis infections.
authors.affiliation: Department of Dermatology, Peking University First Hospital, Research Center for Medical Mycology, Peking University, No. 8, Xishiku St., 100034, Beijing, People's Republic of China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Sun
authors.forename: Wei
authors.initials: W
authors.lastname: Liu
authors.forename: Zhe
authors.initials: Z
authors.lastname: Wan
authors.forename: Xiaohong
authors.initials: X
authors.lastname: Wang
authors.forename: Ruoyu
authors.initials: R
authors.lastname: Li
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D002681:China; D004338:Drug Combinations; D004347:Drug Interactions; D005093:Exophiala / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability / Q000187:drug effects; D009181:Mycoses / Q000382:microbiology
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations
references.citation: Eur J Clin Microbiol Infect Dis. 2003 Sep;22(9):575-6
references.pmid: 12938012
references.citation: Respiration. 2004 Jul-Aug;71(4):360-6
references.pmid: 15316209
references.citation: Expert Rev Anti Infect Ther. 2005 Aug;3(4):601-12
references.pmid: 16107199
references.citation: Mycoses. 1993 Jan-Feb;36(1-2):1-7
references.pmid: 8316255
references.citation: Ann Hematol. 2004 Jun;83(6):390-3
references.pmid: 14666380
references.citation: J Microbiol Methods. 2010 Feb;80(2):138-42
references.pmid: 19961882
references.citation: Med Mycol. 2009;47(6):653-7
references.pmid: 19184769
references.citation: Eur J Pediatr. 1992 May;151(5):344-6
references.pmid: 1396889
references.citation: Med Mycol. 2009 Feb;47(1):101-9
references.pmid: 19107634
references.citation: J Med Microbiol. 2009 Sep;58(Pt 9):1243-1246
references.pmid: 19528179
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):788-90
references.pmid: 19029317
references.citation: J Clin Microbiol. 2002 Oct;40(10):3776-81
references.pmid: 12354880
references.citation: Antimicrob Agents Chemother. 2000 Feb;44(2):470-2
references.pmid: 10639389
references.citation: J Clin Microbiol. 2001 Mar;39(3):954-8
references.pmid: 11230410
references.citation: J Infect Dis. 2003 Jun 15;187(12):1834-43
references.pmid: 12792859
references.citation: J Clin Microbiol. 2004 Dec;42(12):5950-3
references.pmid: 15583351
references.citation: J Antimicrob Chemother. 2006 Dec;58(6):1168-76
references.pmid: 17071635
references.citation: J Child Neurol. 2009 Mar;24(3):342-5
references.pmid: 19258294
references.citation: J Infect. 2006 May;52(5):e133-7
references.pmid: 16427702
references.citation: J Antimicrob Chemother. 2003 Jul;52(1):1
references.pmid: 12805255
references.citation: Scand J Infect Dis. 2001;33(10):777-9
references.pmid: 11728050
references.citation: Expert Opin Pharmacother. 2009 Nov;10(16):2723-33
references.pmid: 19874252
references.citation: Clin Exp Dermatol. 2007 Sep;32(5):539-40
references.pmid: 17524069
references.citation: Can J Infect Dis Med Microbiol. 2008 Jan;19(1):55-62
references.pmid: 19145263
references.citation: Mycoses. 2000 Sep;43(7-8):309-12
references.pmid: 11036402
references.citation: J Am Acad Dermatol. 1983 Jan;8(1):1-16
references.pmid: 6826791
references.citation: Infection. 2007 Oct;35(5):364-6
references.pmid: 17721739
references.citation: Rev Iberoam Micol. 2009 Dec 31;26(4):223-7
references.pmid: 19836985
references.citation: Curr Opin Infect Dis. 2008 Dec;21(6):580-6
references.pmid: 18978525
references.citation: Cancer. 2003 Feb 15;97(4):1025-32
references.pmid: 12569602
references.citation: Mycopathologia. 1987 Sep;99(3):175-81
references.pmid: 3657909
references.citation: Respir Med. 2006 Nov;100(11):2069-71
references.pmid: 16626952
references.citation: Blood. 2005 Oct 15;106(8):2641-5
references.pmid: 15998833
references.citation: Lancet. 2003 Oct 4;362(9390):1142-51
references.pmid: 14550704
references.citation: J Antimicrob Chemother. 2009 Feb;63(2):340-2
references.pmid: 19054803
references.citation: Med Mycol. 2009 Feb;47(1):41-3
references.pmid: 19107637
references.citation: Rev Iberoam Micol. 2008 Jun;25(2):101-6
references.pmid: 18473504
references.citation: Lancet Infect Dis. 2009 Jun;9(6):376-83
references.pmid: 19467477